TAVALISSE
Rigel Pharmaceuticals, Inc.
Application Filed: 2017-04-11
Trademark Application Details
SECOND EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87407547 |
| Registration Number | 5822266 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Attorney Name | Diane J. Mason |
| Attorney Docket Number | 55783.2007 |
| Law Office Assigned | M40 |
| Employee Name | RICHARDSON, JENNIFER D |
Timeline
| 2017-04-11 | Application Filed |
| 2017-08-29 | Published for Opposition |
| 2017-10-24 | Location: INTENT TO USE SECTION |
| 2018-10-24 | Status: Live/Pending |
| 2019-04-25 | Transaction Date |
| 2019-07-30 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Rigel Pharmaceuticals, Inc. |
| Address | 1180 Veterans Boulevard San Francisco DE 94080 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260118 | Circles, three or more concentric; Concentric circles, three or more; Three or more concentric circles |
| 260120 | Circles within a circle |
| 260121 | Circles that are totally or partially shaded. |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| CC0000 | The color(s) gray, green and orange is/are claimed as a feature of the mark. |
| CC0000 | The color(s) gray, green and orange is/are claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-04-14 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-04-19 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2017-04-20 | 3 MDSC E:E-Mail |
| ASSIGNED TO EXAMINER | 2017-07-03 | 4 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2017-07-07 | 5 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2017-07-07 | 6 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-07-07 | 7 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2017-07-07 | 8 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-07-07 | 9 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-08-09 | 10 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-08-29 | 11 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-08-29 | 12 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-10-24 | 13 NOAM E:E-Mail |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2018-04-24 | 14 TCCA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2018-04-24 | 15 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2018-04-24 | 16 EXT1 S: |
| EXTENSION 1 GRANTED | 2018-04-24 | 17 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-04-26 | 18 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-10-24 | 19 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2018-10-24 | 20 EXT2 S: |
| EXTENSION 2 GRANTED | 2018-10-24 | 21 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-10-26 | 22 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2019-04-24 | 23 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-05-07 | 24 AITU A:Allowance for Publication |
| USE AMENDMENT FILED | 2019-04-24 | 25 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2019-05-07 | 26 SUPC I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-05-13 | 27 TCCA I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2019-06-26 | 28 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2019-06-27 | 29 SUNA E:E-Mail |
| ASSIGNED TO EXAMINER | 2019-07-08 | 30 DOCK D:Assigned to Examiner |
| REGISTERED-PRINCIPAL REGISTER | 2019-07-30 | 31 R.PR A:Allowance for Publication |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-03-17 | 32 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-03-17 | 33 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-03-17 | 34 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-03-17 | 35 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-03-17 | 36 CHAN I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-02-03 | 37 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-02-03 | 38 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-02-03 | 39 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-02-03 | 40 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-02-03 | 41 CHAN I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TAVALISSE 87407547 not registered Live/Pending |
Rigel Pharmaceuticals, Inc. 2017-04-11 |
 TAVALISSE 87144949 5638421 Live/Registered |
Rigel Pharmaceuticals, Inc. 2016-08-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 